logo
Select company
Select metric
3.76Cash Ratio
VS
Market
90
Sector
81
Industry
72
History
52
$ 2.37Close
$ 1.36 - $ 6.35 52-Week Range
Ticker Information

Ticker

CYCN

Company Name

CYCLERION THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CYCLERION THERAPEUTICS INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CYCN - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 3.01M3.76$ 800K
3/31/2025$ 3.64M3.41$ 1.07M
12/31/2024$ 3.23M4.46$ 725K
9/30/2024$ 2.87M4.1$ 700K
6/30/2024$ 4.59M3.58$ 1.28M
3/31/2024$ 5.7M3.95$ 1.44M
12/31/2023$ 7.57M3.63$ 2.09M
9/30/2023$ 9.11M3.89$ 2.34M
6/30/2023$ 5.64M1.14$ 4.95M
3/31/2023$ 7.17M0.95$ 7.53M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CYCLERION THERAPEUTICS INC's latest trailing twelve months (TTM) Cash Ratio stands at 4.11.
  • Over the past 5 years, CYCLERION THERAPEUTICS INC's average Cash Ratio has been 3.59.
  • The median Cash Ratio for CYCLERION THERAPEUTICS INC during this period was 3.69
  • CYCLERION THERAPEUTICS INC reached its highest Cash Ratio over the past 5 years at 6.7.
  • The lowest Cash Ratio recorded by CYCLERION THERAPEUTICS INC in the same timeframe 0.95

CYCLERION THERAPEUTICS INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
LGVN : LONGEVERON INC 3.15TRAW : TRAWS PHARMA INC 1.78APRE : APREA THERAPEUTICS INC 5.23XBIO : XENETIC BIOSCIENCES INC 5.29LUCY : INNOVATIVE EYEWEAR INC 12.59LYRA : LYRA THERAPEUTICS INC 2.85VYNE : VYNE THERAPEUTICS INC 3.78SINT : SINTX TECHNOLOGIES INC 2SPRB : SPRUCE BIOSCIENCES INC 2.03ONCO : ONCONETIX INC 0.02

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for CYCLERION THERAPEUTICS INC is calculated as follows: CashnEq [ $ 66.84M ] / LiabilitesC [ $ 16.26M ]
(=) Cash Ratio [ 4.11 ]

CYCN - Cash Ratio, Last 5 years

0.95

Minimum

Mar 31, 2023

6.7

Maximum

Jun 30, 2021

3.59

Average

3.69

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63